Kumamoto, Takafumi
128  Ergebnisse:
Personensuche X
?
 
?
4

Multicenter randomized phase II study on S-1 and oxaliplati..:

Ozawa, Mayumi ; Watanabe, Jun ; Ishibe, Atsushi...
Cancer Chemotherapy and Pharmacology.  93 (2024)  6 - p. 565-573 , 2024
 
?
5

Requirements for hospitals in Japan to have low operative m..:

Endo, Itaru ; Takahashi, Arata ; Tachimori, Hisateru...
Annals of Gastroenterological Surgery.  8 (2023)  2 - p. 342-355 , 2023
 
?
7

Outcomes of neoadjuvant gemcitabine plus S‐1 and radiation ..:

Yabushita, Yasuhiro ; Matsuyama, Ryusei ; Miyake, Kentaro...
Journal of Hepato-Biliary-Pancreatic Sciences.  30 (2022)  4 - p. 493-502 , 2022
 
?
9

Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on B..:

Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei...
Annals of Surgical Oncology.  29 (2022)  4 - p. 2393-2405 , 2022
 
?
10

ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuv..:

Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei...
Annals of Surgical Oncology.  29 (2022)  4 - p. 2406-2406 , 2022
 
?
12

Essential updates 2019/2020: Surgical treatment of gallblad..:

Matsuyama, Ryusei ; Yabusita, Yasuhiro ; Homma, Yuki..
Annals of Gastroenterological Surgery.  5 (2021)  2 - p. 152-161 , 2021
 
?
15

Significance of HMGA2 expression as independent poor progno..:

Takahashi, Tomoaki ; Kawaji, Hideya ; Murakawa, Yasuhiro...
European Journal of Surgical Oncology.  47 (2021)  2 - p. 394-400 , 2021
 
1-15